Celanese Targets $1 B Asset Sales and $1–$2 EPS Boost in 2026
Celanese cites Q4 Acetyl Chain earnings decline from lower volume and pricing plus China margin compression, and targets $1 billion of divestitures by end-2027 after a nine-month Micromax sale. Management expects a $1–$2 EPS lift in 2026, driven by Engineered Materials growth and cost actions including Lanaken closure saving $20–25 million.
1. Q4 Acetyl Chain and Engineered Materials Results
Celanese reported a Q4 earnings decline in its Acetyl Chain segment due to lower volumes, pricing pressure and margin compression in China. Engineered Materials also faced volume and price drops of similar magnitude, partially offset by cost reduction measures and improved variable margin management.
2. Divestiture Plan to Raise $1 B by 2027
Management reiterated its goal of $1 billion in divestiture proceeds by the end of 2027, noting it is already halfway there. The sale of Micromax completed in nine months exemplifies execution speed, and another deal is expected in 2026 to support debt reduction and deleveraging.
3. 2026 Outlook: EPS Lift and Growth Levers
Celanese projects a $1–$2 EPS increase for 2026 driven by controlled growth in Engineered Materials, continued cost actions and selective Acetyl Chain opportunities as market conditions improve. Electronics demand tied to AI and data centers offers upside, while automotive trends remain mixed across regions.
4. Cost Actions and Free Cash Flow Initiatives
Key cost actions include the Lanaken plant closure, expected to deliver $20–25 million in annual savings. Free cash flow drivers for 2026 target $100 million of working capital reductions, $50–60 million lower cash taxes and $50 million of interest savings, reinforcing a cash-first strategy.